CEP290

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Centrosomal protein 290kDa
Identifiers
Symbols CEP290 ; 3H11Ag; BBS14; CT87; JBTS5; LCA10; MKS4; NPHP6; POC3; SLSN6; rd16
External IDs OMIM610142 HomoloGene77213 GeneCards: CEP290 Gene
RNA expression pattern
PBB GE CEP290 205250 s at tn.png
PBB GE CEP290 221683 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 80184 216274
Ensembl ENSG00000198707 ENSMUSG00000019971
UniProt O15078 Q6A078
RefSeq (mRNA) NM_025114 NM_146009
RefSeq (protein) NP_079390 NP_666121
Location (UCSC) Chr 12:
88.44 – 88.54 Mb
Chr 10:
100.49 – 100.57 Mb
PubMed search [3] [4]

Centrosomal protein of 290 kDa is a protein that in humans is encoded by the CEP290 gene.[1][2][3][4] CEP290 is located on the Q arm of chromosome 12.

Function[edit]

The gene CEP290 is a centrosomal protein that plays an important role in centrosome and cilia development. This gene is vital in the formation of the primary cilium, a small antenna-like projections of the cell membrane that plays an important role in the photoreceptors at the back of the retina (which detect light and color) and in the kidney, brain, and many other organs of the body. Knocking down levels of the CEP290 gene transcript resulted in dramatic suppression of ciliogenesis in retinal pigment epithelial cells in culture, proving just how important CEP290 is to cilia formation.

On a molecular level, CEP290 has been shown to play a critical regulatory and structural role in primary cilium formation. Recent studies have implicated CEP290 as a microtubule and membrane binding protein that might serve as a structural link between the microtubule core of the cilium and the overlying ciliary membrane.[5] Disruption of CEP290's microtubule binding domain in the rd16 mouse model of CEP290 disease [3] has been shown to result in rapid and dramatic retinal degeneration, demonstrating the importance of CEP290 microtubule binding in disease. The role of CEP290 in promoting ciliogensis is inhibited both by auto-regulatory domains found at either end of the CEP290 protein [5] and through CEP290's interaction with the inhibitory protein CP110.[6]

The discovery of the CEP290 gene has led researchers to find another gene critical in retinal function, LCA5. Clinical trials involving gene replacement of these two genes have started in Philadelphia, where researchers are hopeful that Leber Congenital Amaurosis will one day be cured.[7][8][9]

Structure[edit]

This gene encodes a protein with 13 putative coiled-coil domains, a region with homology to SMC chromosome segregation ATPases, six KID motifs, three tropomyosin homology domains and an ATP/GTP binding site motif A. The protein is localized to the centrosome and cilia and has sites for N-glycosylation, tyrosine sulfation, phosphorylation, N-myristoylation, and amidation.[4]

Clinical significance[edit]

Mutations in this gene have been associated with Joubert syndrome and nephronophthisis, and recently with a frequent form of Leber's Congenital Amaurosis, called LCA10. The presence of antibodies against this protein is associated with several forms of cancer.[4]

A mutation in this gene leads to infant and child blindness, a disease known as Leber Congenital Amaurosis. As of today, 35 different mutations in CEP290 are responsible for causing LCA. Other mutations in CEP290 have also been identified in causing Meckel Syndrome and Joubert Syndrome, a few among many syndromes. A defective CEP290 gene is usually the cause of these disorders due to abnormal cilia. It is unknown how one mutation in a gene can cause so many different types of syndromes, particularly many of which affect the Central Nervous System.

References[edit]

  1. ^ Guo J, Jin G, Meng L, Ma H, Nie D, Wu J, Yuan L, Shou C (Oct 2004). "Subcellullar localization of tumor-associated antigen 3H11Ag". Biochem Biophys Res Commun 324 (2): 922–30. doi:10.1016/j.bbrc.2004.09.133. PMID 15474516. 
  2. ^ Sayer JA, Otto EA, O'Toole JF, Nurnberg G, Kennedy MA, Becker C, Hennies HC, Helou J, Attanasio M, Fausett BV, Utsch B, Khanna H, Liu Y, Drummond I, Kawakami I, Kusakabe T, Tsuda M, Ma L, Lee H, Larson RG, Allen SJ, Wilkinson CJ, Nigg EA, Shou C, Lillo C, Williams DS, Hoppe B, Kemper MJ, Neuhaus T, Parisi MA, Glass IA, Petry M, Kispert A, Gloy J, Ganner A, Walz G, Zhu X, Goldman D, Nurnberg P, Swaroop A, Leroux MR, Hildebrandt F (May 2006). "The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4". Nat Genet 38 (6): 674–81. doi:10.1038/ng1786. PMID 16682973. 
  3. ^ a b Chang B, Khanna H, Hawes N, Jimeno D, He S, Lillo C, Parapuram SK, Cheng H, Scott A, Hurd RE, Sayer JA, Otto EA, Attanasio M, O'Toole JF, Jin G, Shou C, Hildebrandt F, Williams DS, Heckenlively JR, Swaroop A (May 2006). "In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse". Hum Mol Genet 15 (11): 1847–57. doi:10.1093/hmg/ddl107. PMC 1592550. PMID 16632484. 
  4. ^ a b c "Entrez Gene: CEP290 centrosomal protein 290kDa". 
  5. ^ a b Drivas TG, Holzbaur EL, Bennett J. (Oct 2013). "Disruption of CEP290 microtubule/membrane-binding domains causes retinal degeneration.". J Clin Invest 123 (10): 4525–39. doi:10.1172/JCI69448. PMC 3784542. PMID 24051377. 
  6. ^ Tsang WY, Bossard C, Khanna H, Peränen J, Swaroop A, Malhotra V, Dynlacht BD. (Aug 2008). "CP110 suppresses primary cilia formation through its interaction with CEP290, a protein deficient in human ciliary disease.". Dev Cell. 15 (2): 187–97. doi:10.1016/j.devcel.2008.07.004. PMC 3987787. PMID 18694559. 
  7. ^ Kniffin, Cassandra L. "OMIM Entry Centrosomal Protein 290-KD." [1] N.p., 24 May 2006. Web. 30 Mar. 2013.
  8. ^ "Genetics Home Reference Gene CEP290." [2]. US National LIbrary of Medicine, 25 Mar. 2013. Web. 30 Mar. 2013.
  9. ^ McGill University Health Centre. "Gene Responsible For Blindness In Infants And Children Identified." ScienceDaily, 4 Jun. 2007. Web. 30 Mar. 2013.

External links[edit]

Further reading[edit]